{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T14:26:31Z","timestamp":1792765591705,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.heliyon.2024.e34506","type":"journal-article","created":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T06:09:59Z","timestamp":1720678199000},"page":"e34506","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Expression pattern analysis of the MAGE family genes in breast cancer patients and hypomethylation activation in the MCF-7 cells"],"prefix":"10.1016","volume":"10","author":[{"given":"Ahmad M.","family":"Almatrafi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman","family":"Alamery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0337-6412","authenticated-orcid":false,"given":"Mikhlid H.","family":"Almutairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.heliyon.2024.e34506_bib1","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41416-021-01328-7","article-title":"Breast cancer as an example of tumour heterogeneity and tumour cell plasticity during malignant progression","volume":"125","author":"Luond","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e34506_bib2","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaoncol.2015.0735","article-title":"The global burden of cancer 2013","volume":"1","author":"Fitzmaurice","year":"2015","journal-title":"JAMA Oncol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34506_bib3","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.heliyon.2024.e34506_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100985","article-title":"Global breast cancer incidence and mortality trends by region, age-groups, and fertility patterns","volume":"38","author":"Lima","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34506_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003284","article-title":"Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors","volume":"9","author":"Nickels","year":"2013","journal-title":"PLoS Genet."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34506_bib6","first-page":"679","article-title":"Epidemiology of cancer in Saudi Arabia thru 2010-2019: a systematic review with constrained meta-analysis","volume":"7","author":"Alqahtani","year":"2020","journal-title":"AIMS Public Health"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e34506_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206148","article-title":"Breast cancer mortality in Saudi Arabia: modelling observed and unobserved factors","volume":"13","author":"Alotaibi","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2024.e34506_bib8","article-title":"Delays in breast cancer detection and treatment in developing countries","volume":"12","author":"Rivera-Franco","year":"2018","journal-title":"Breast Cancer"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e34506_bib9","doi-asserted-by":"crossref","first-page":"843","DOI":"10.18632\/oncotarget.580","article-title":"Meta-analysis of clinical data using human meiotic genes identifies a novel cohort of highly restricted cancer-specific marker genes","volume":"3","author":"Feichtinger","year":"2012","journal-title":"Oncotarget"},{"issue":"51","key":"10.1016\/j.heliyon.2024.e34506_bib10","doi-asserted-by":"crossref","first-page":"20422","DOI":"10.1073\/pnas.0810777105","article-title":"Genome-wide analysis of cancer\/testis gene expression","volume":"105","author":"Hofmann","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.heliyon.2024.e34506_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/ITT.S35570","article-title":"Cancer testis antigen and immunotherapy","volume":"2","author":"Krishnadas","year":"2013","journal-title":"ImmunoTargets Ther."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34506_bib12","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.molonc.2011.02.001","article-title":"The biology of cancer testis antigens: putative function, regulation and therapeutic potential","volume":"5","author":"Fratta","year":"2011","journal-title":"Mol. Oncol."},{"issue":"5038","key":"10.1016\/j.heliyon.2024.e34506_bib13","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1126\/science.1840703","article-title":"A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma","volume":"254","author":"van der Bruggen","year":"1991","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e34506_bib14","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.trecan.2018.08.005","article-title":"Emerging contributions of cancer\/testis antigens to neoplastic behaviors","volume":"4","author":"Gibbs","year":"2018","journal-title":"Trends Cancer"},{"issue":"Database issue","key":"10.1016\/j.heliyon.2024.e34506_bib15","doi-asserted-by":"crossref","first-page":"D816","DOI":"10.1093\/nar\/gkn673","article-title":"CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens","volume":"37","author":"Almeida","year":"2009","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e34506_bib16","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1002\/jcb.23252","article-title":"A majority of the cancer\/testis antigens are intrinsically disordered proteins","volume":"112","author":"Rajagopalan","year":"2011","journal-title":"J. Cell. Biochem."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e34506_bib17","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/08820139.2016.1197241","article-title":"Cancer\/testis antigens: expression, regulation, tumor invasion, and use in immunotherapy of cancers","volume":"45","author":"Salmaninejad","year":"2016","journal-title":"Immunol. Invest."},{"issue":"32","key":"10.1016\/j.heliyon.2024.e34506_bib18","doi-asserted-by":"crossref","first-page":"13493","DOI":"10.1073\/pnas.0906840106","article-title":"CT-X antigen expression in human breast cancer","volume":"106","author":"Grigoriadis","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e34506_bib19","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nrc1669","article-title":"Cancer\/testis antigens, gametogenesis and cancer","volume":"5","author":"Simpson","year":"2005","journal-title":"Nat. Rev. Cancer"},{"issue":"47","key":"10.1016\/j.heliyon.2024.e34506_bib20","doi-asserted-by":"crossref","first-page":"8496","DOI":"10.1016\/j.vaccine.2011.09.014","article-title":"MAGE-A family: attractive targets for cancer immunotherapy","volume":"29","author":"Sang","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.heliyon.2024.e34506_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ceb.2015.08.002","article-title":"The MAGE protein family and cancer","volume":"37","author":"Weon","year":"2015","journal-title":"Curr. Opin. Cell Biol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34506_bib22","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/CJI.0000000000000013","article-title":"Expression of MAGE-A3\/6 in primary breast cancer is associated with hormone receptor negative status, high histologic grade, and poor survival","volume":"37","author":"Ayyoub","year":"2014","journal-title":"J. Immunother."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34506_bib23","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.amjsurg.2015.05.028","article-title":"The expression of MAGE-C1 and MAGE-C2 in breast cancer and their clinical significance","volume":"211","author":"Hou","year":"2016","journal-title":"Am. J. Surg."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34506_bib24","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.arcmed.2013.10.005","article-title":"Expressions of MAGE-A9 and MAGE-A11 in breast cancer and their expression mechanism","volume":"45","author":"Hou","year":"2014","journal-title":"Arch. Med. Res."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e34506_bib25","first-page":"3501","article-title":"Prognostic roles of MAGE family members in breast cancer based on KM-Plotter Data","volume":"18","author":"Jia","year":"2019","journal-title":"Oncol. Lett."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e34506_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104099","article-title":"Expression and immune responses to MAGE antigens predict survival in epithelial ovarian cancer","volume":"9","author":"Daudi","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34506_bib27","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3109\/1354750X.2013.865275","article-title":"Multiple MAGE-A genes as surveillance marker for the detection of circulating tumor cells in patients with ovarian cancer","volume":"19","author":"Sang","year":"2014","journal-title":"Biomarkers"},{"key":"10.1016\/j.heliyon.2024.e34506_bib28","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6066567","article-title":"Expression profile of MAGE-B1 gene and its hypomethylation activation in colon cancer","volume":"2022","author":"Almutairi","year":"2022","journal-title":"BioMed Res. Int."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34506_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/genes13050807","article-title":"Cancer-testis gene biomarkers discovered in colon cancer patients","volume":"13","author":"Almutairi","year":"2022","journal-title":"Genes"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e34506_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021366","article-title":"MAGE-C2\/CT10 protein expression is an independent predictor of recurrence in prostate cancer","volume":"6","author":"von Boehmer","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34506_bib31","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.3892\/ol.2017.5665","article-title":"Expression and prognostic relevance of MAGE-A3 and MAGE-C2 in non-small cell lung cancer","volume":"13","author":"Chen","year":"2017","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34506_bib32","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.lungcan.2006.12.004","article-title":"Differential expression profile of MAGE family in non-small-cell lung cancer","volume":"56","author":"Tsai","year":"2007","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34506_bib33","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/ijc.2910630313","article-title":"Expression of MAGE genes in primary and metastatic cutaneous melanoma","volume":"63","author":"Brasseur","year":"1995","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34506_bib34","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00008390-200010030-00008","article-title":"MAGE-12 and MAGE-6 are frequently expressed in malignant melanoma","volume":"10","author":"Gibbs","year":"2000","journal-title":"Melanoma Res."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e34506_bib35","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.cell.2015.01.034","article-title":"Degradation of AMPK by a cancer-specific ubiquitin ligase","volume":"160","author":"Pineda","year":"2015","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34506_bib36","first-page":"541","article-title":"High expression of MAGE-A9 in tumor and stromal cells of non-small cell lung cancer was correlated with patient poor survival","volume":"8","author":"Zhang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"19","key":"10.1016\/j.heliyon.2024.e34506_bib37","doi-asserted-by":"crossref","first-page":"8104","DOI":"10.1158\/0008-5472.CAN-08-2132","article-title":"The melanoma-associated antigen A3 mediates fibronectin-controlled cancer progression and metastasis","volume":"68","author":"Liu","year":"2008","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34506_bib38","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/jid.2012.355","article-title":"MAGE-C2 promotes growth and tumorigenicity of melanoma cells, phosphorylation of KAP1, and DNA damage repair","volume":"133","author":"Bhatia","year":"2013","journal-title":"J. Invest. Dermatol."},{"issue":"20","key":"10.1016\/j.heliyon.2024.e34506_bib39","doi-asserted-by":"crossref","first-page":"9954","DOI":"10.1158\/0008-5472.CAN-07-1478","article-title":"MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines","volume":"67","author":"Yang","year":"2007","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34506_bib40","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/BF01246677","article-title":"Structure, chromosomal localization, and expression of 12 genes of the MAGE family","volume":"40","author":"De Plaen","year":"1994","journal-title":"Immunogenetics"},{"issue":"18","key":"10.1016\/j.heliyon.2024.e34506_bib41","first-page":"6682","article-title":"MAGE-A gene expression pattern in primary breast cancer","volume":"61","author":"Otte","year":"2001","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34506_bib42","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1006\/geno.1997.5052","article-title":"Two members of the human MAGEB gene family located in Xp21.3 are expressed in tumors of various histological origins","volume":"46","author":"Lurquin","year":"1997","journal-title":"Genomics"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34506_bib43","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s10517-018-4175-x","article-title":"Specific features of transcription activity of cancer-testis antigens in patients with metastatic and non-metastatic breast cancer","volume":"165","author":"Vodolazhsky","year":"2018","journal-title":"Bull. Exp. Biol. Med."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34506_bib44","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1023\/A:1016367104015","article-title":"Potential mouse tumor model for pre-clinical testing of mage-specific breast cancer vaccines","volume":"74","author":"Sypniewska","year":"2002","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34506_bib45","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10549-004-6454-7","article-title":"Prevention of metastases with a Mage-b DNA vaccine in a mouse breast tumor model: potential for breast cancer therapy","volume":"91","author":"Sypniewska","year":"2005","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34506_bib46","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/1097-0215(20000701)87:1<55::AID-IJC8>3.0.CO;2-J","article-title":"MAGE-B5, MAGE-B6, MAGE-C2, and MAGE-C3: four new members of the MAGE family with tumor-specific expression","volume":"87","author":"Lucas","year":"2000","journal-title":"Int. J. Cancer"},{"issue":"24","key":"10.1016\/j.heliyon.2024.e34506_bib47","doi-asserted-by":"crossref","first-page":"9167","DOI":"10.1158\/0008-5472.CAN-04-1442","article-title":"Intratumor heterogeneity of cancer\/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2'-deoxycytidine","volume":"64","author":"Sigalotti","year":"2004","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34506_bib48","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1158\/1541-7786.MCR-05-0229","article-title":"Promoter demethylation and histone acetylation mediate gene expression of MAGE-A1, -A2, -A3, and -A12 in human cancer cells","volume":"4","author":"Wischnewski","year":"2006","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.heliyon.2024.e34506_bib49","volume":"vol. 34","author":"Almutairi","year":"2022"},{"issue":"W1","key":"10.1016\/j.heliyon.2024.e34506_bib50","doi-asserted-by":"crossref","first-page":"W207","DOI":"10.1093\/nar\/gkad347","article-title":"g:Profiler-interoperable web service for functional enrichment analysis and gene identifier mapping (2023 update)","volume":"51","author":"Kolberg","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"10.1016\/j.heliyon.2024.e34506_bib51","doi-asserted-by":"crossref","first-page":"W199","DOI":"10.1093\/nar\/gkz401","article-title":"WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs","volume":"47","author":"Liao","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e34506_bib52","doi-asserted-by":"crossref","first-page":"745","DOI":"10.18632\/oncoscience.95","article-title":"Identification of a class of human cancer germline genes with transcriptional silencing refractory to the hypomethylating drug 5-aza-2'-deoxycytidine","volume":"1","author":"Almatrafi","year":"2014","journal-title":"Oncoscience"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34506_bib53","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.yexmp.2014.11.001","article-title":"Overexpression of MAGE-A9 predicts unfavorable outcome in breast cancer","volume":"97","author":"Xu","year":"2014","journal-title":"Exp. Mol. Pathol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34506_bib54","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1074\/mcp.M112.019786","article-title":"Proteomic profiling of triple-negative breast carcinomas in combination with a three-tier orthogonal technology approach identifies Mage-A4 as potential therapeutic target in estrogen receptor negative breast cancer","volume":"12","author":"Cabezon","year":"2013","journal-title":"Mol. Cell. Proteomics"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e34506_bib55","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.molcel.2010.08.029","article-title":"MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases","volume":"39","author":"Doyle","year":"2010","journal-title":"Mol. Cell"},{"issue":"22","key":"10.1016\/j.heliyon.2024.e34506_bib56","doi-asserted-by":"crossref","first-page":"8055","DOI":"10.1158\/1078-0432.CCR-05-1203","article-title":"Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer","volume":"11","author":"Gure","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e34506_bib57","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1002\/ijc.21656","article-title":"The clinical significance of MAGEA3 expression in pancreatic cancer","volume":"118","author":"Kim","year":"2006","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e34506_bib58","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1245\/s10434-010-1399-z","article-title":"Clinical significance of melanoma antigen-encoding gene-1 (MAGE-1) expression and its correlation with poor prognosis in differentiated advanced gastric cancer","volume":"18","author":"Ogata","year":"2011","journal-title":"Ann. Surg Oncol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34506_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11050677","article-title":"MAGE-A3 is a clinically relevant target in undifferentiated pleomorphic sarcoma\/myxofibrosarcoma","volume":"11","author":"Conley","year":"2019","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e34506_bib60","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1136\/jclinpath-2019-206175","article-title":"High methionyl-tRNA synthetase expression predicts poor prognosis in patients with breast cancer","volume":"73","author":"Jin","year":"2020","journal-title":"J. Clin. Pathol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e34506_bib61","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00262-008-0582-6","article-title":"Treatment of ovarian cancer cell lines with 5-aza-2'-deoxycytidine upregulates the expression of cancer-testis antigens and class I major histocompatibility complex-encoded molecules","volume":"58","author":"Adair","year":"2009","journal-title":"Cancer Immunol. Immunother."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34506_bib62","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.21037\/tcr.2020.01.10","article-title":"5-aza-2'-deoxycytidine (DAC) treatment induces the MAGE-A10 expression and improves the cytotoxicity of MAGE-A10-specific CTLs in lung cancer cells","volume":"9","author":"Li","year":"2020","journal-title":"Transl. Cancer Res."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34506_bib63","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1124\/mol.65.1.18","article-title":"Limited gene activation in tumor and normal epithelial cells treated with the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine","volume":"65","author":"Karpf","year":"2004","journal-title":"Mol. Pharmacol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e34506_bib64","first-page":"821","article-title":"[Expression of melanoma-associated antigen-C2 in breast cancers and mechanism]","volume":"43","author":"Li","year":"2021","journal-title":"Zhonghua Zhongliu Zazhi"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e34506_bib65","doi-asserted-by":"crossref","first-page":"583","DOI":"10.21873\/cgp.20161","article-title":"Proteomic analysis of primary colon cancer and synchronous solitary liver metastasis","volume":"16","author":"Kim","year":"2019","journal-title":"Cancer Genomics Proteomics"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024105373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024105373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T13:33:03Z","timestamp":1773840783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024105373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":65,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S2405844024105373"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34506","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression pattern analysis of the MAGE family genes in breast cancer patients and hypomethylation activation in the MCF-7 cells","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34506","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e34506"}}